|
Volumn 13, Issue 9, 2000, Pages 954-961
|
Pathologic, cytogenetic and molecular assessment of acute promyelocytic leukemia patients treated with arsenic trioxide (As2O3)
a b c |
Author keywords
Acute promyelocytic leukemia; All trans retinoic acid; Arsenic trioxide
|
Indexed keywords
ARSENIC TRIOXIDE;
RETINOIC ACID;
ACUTE LEUKEMIA;
ACUTE MYELOBLASTIC LEUKEMIA;
ADULT;
AGED;
ARTICLE;
CLINICAL ARTICLE;
CLINICAL PROTOCOL;
CLINICAL TRIAL;
CYTOGENETICS;
CYTOLYSIS;
DOSE RESPONSE;
FEMALE;
HUMAN;
HUMAN CELL;
IMMUNOPHENOTYPING;
LEUKOCYTOSIS;
MALE;
PHASE 1 CLINICAL TRIAL;
PHASE 2 CLINICAL TRIAL;
PRIORITY JOURNAL;
TREATMENT OUTCOME;
|
EID: 0033799995
PISSN: 08933952
EISSN: None
Source Type: Journal
DOI: 10.1038/modpathol.3880174 Document Type: Article |
Times cited : (21)
|
References (19)
|